Quick Answer: STI rates may appear lower in recent years, but this often reflects reduced testing rather than an actual decline in infections. Less testing means more undiagnosed cases, especially among asymptomatic carriers.
Behind the Dip: What "Lower Rates" Are Really Showing
Let’s get brutally honest: numbers can lie. Or more accurately, numbers can tell a partial truth. Reported STI cases in the U.S. saw a drop of roughly 9% between 2023 and 2024, according to provisional data from the CDC. That sounds promising, until you realize that chlamydia testing also dropped across major urban centers during that same period. And without tests, there are no cases to report.
Think of it like this: if you stop taking your temperature, you might think your fever went away. But did it?
The decline is even more suspicious when viewed alongside the long-term arc: STI rates today are still significantly higher than a decade ago. So while the short-term trend line looks like a win, the broader reality tells a different story.
When the Tests Vanish, So Do the Diagnoses
Fewer people testing doesn’t mean fewer people are infected. It just means more are walking around unaware, and possibly spreading infections without knowing. One study published in PLOS ONE found that post-COVID testing rates for common STIs like chlamydia and gonorrhea dropped significantly, especially in primary care settings. Meanwhile, testing positivity remained the same, or even increased, suggesting that the actual number of cases didn’t drop at all.
In the UK, the Nuffield Trust reported that chlamydia screening rates among young adults have halved since 2012. Unsurprisingly, diagnoses also fell. But epidemiologists are quick to point out: that’s not because people are safer. It’s because fewer people are being checked.
Case Study: “I Got a Negative Test. I Still Gave My Partner Herpes.”
Marcus, 28, took an at-home STI test after a breakup. It came back negative, and he felt relieved, clean, cleared, safe. But six weeks later, his new partner developed symptoms that led to a positive HSV-2 diagnosis. Marcus was confused and ashamed. A follow-up lab test confirmed he had been carrying the virus all along, he’d just tested too soon.
“I thought I was being responsible,” he said. “I did the test. I followed the rules. But I guess I didn’t really know the timing.”
This is how false security sets in, not from irresponsibility, but from a system that doesn’t communicate how testing really works. Marcus didn’t skip care. He just didn’t know about the window period.

People are also reading: You Slept with Someone New, When Should You Retest?
Table: How Testing Volumes Shape Reported STI Numbers
| Year | Chlamydia Tests (U.S.) | Reported Chlamydia Cases | Positivity Rate |
|---|---|---|---|
| 2022 | 4.9 million | 1.65 million | 33.7% |
| 2023 | 4.1 million | 1.52 million | 37.1% |
| 2024 (projected) | 3.7 million | 1.38 million | 37.3% |
Figure 1. Even as total test volume dropped, the positivity rate for chlamydia rose, suggesting undetected cases remained high.
The Danger of Asymptomatic Spread
One of the biggest myths about STIs is that you’ll know if you have one. But many infections, especially chlamydia, HPV, and herpes, can lie dormant with no visible symptoms. This is where reduced testing becomes especially dangerous. People don’t feel sick, so they don’t get screened. And because fewer are tested, public health agencies underreport the actual infection load in the community.
According to the World Health Organization, STIs remain a massive global burden, an estimated 374 million new infections annually across just four major infections. The only thing that’s down in many places? The testing infrastructure.
Testing isn’t just a personal health tool, it’s the flashlight that reveals what’s really happening at the population level.
Check Your STD Status in Minutes
Test at Home with Remedium6-in-1 STD Test Kit

Order Now $119.00 $294.00
For all 6 tests
Testing Trends Tell a Different Story
In a small town clinic in Oklahoma, a nurse practitioner named Rachel keeps track of her STD screening appointments by hand. In 2019, she was running five to six panels a day. Now? She’s lucky if she sees three people a week. Not because demand is down, people still come in with symptoms, exposure concerns, or requests for birth control, but fewer patients agree to full STI screening unless they absolutely have to.
“They say they’re monogamous, or they feel fine,” Rachel says. “They think that if they’re not showing symptoms, they’re safe. But I’ve seen two silent syphilis cases this month alone.”
Her story isn’t unique. Across the U.S. and UK, sexual health professionals are watching screening rates fall while infections remain constant, or worse, grow under the radar. A report by the Nuffield Trust showed a stark reduction in screening for asymptomatic people, particularly in younger age groups. And according to the CDC, most infections in 2023 occurred in people aged 15–24, many of whom were never tested unless symptoms pushed them to a clinic.
It’s not that fewer people have STIs, it’s that fewer people are looking.
Why False Negatives Are Part of the Problem
Let’s say you get tested. You’re being responsible. You feel empowered. But what if the test was too early? Or the method wasn’t sensitive enough? Suddenly that clean result is more like a placeholder, a maybe instead of a no. This is how false negatives become part of the reporting problem, especially when people test right after exposure or during the “window period” where infections haven’t reached detectable levels yet.
That’s what happened to Andrea, 25, who took a rapid test after an unprotected hookup. It came back negative for gonorrhea, so she brushed off the mild discharge she noticed days later. Three weeks later, she was in urgent care with full pelvic inflammatory disease. The infection had been there all along, it just didn’t show up on that first screen.
“I blamed myself for not waiting longer,” she said. “But no one told me that timing mattered that much.”
And yet, her case would never appear in the “gonorrhea case totals” from her initial test. It wasn’t diagnosed until much later, by a different provider, after damage had already been done.
Table: Window Periods vs STI Reporting Accuracy
| STD | Recommended Testing Window After Exposure | Risk of False Negative If Tested Early |
|---|---|---|
| Chlamydia | 7–14 days | High (before day 7) |
| Gonorrhea | 7–14 days | High (before day 7) |
| Syphilis | 3–6 weeks | Very high (first 2 weeks) |
| Herpes (HSV-2) | 4–12 weeks (antibody test) | Very high if tested before week 4 |
| HIV (4th-gen) | 18–45 days | Moderate (if < 18 days) |
Figure 2. Testing too soon after exposure can result in false negatives, especially for infections with longer incubation periods like syphilis and herpes.
What Public Health Surveillance Can, and Can’t, Tell Us
Public health data works like a rearview mirror. It reflects what’s already happened, but only if someone reports it. And those reports depend on people getting tested, the right test being used, and the result being logged. Every link in that chain has weak spots. Lose enough of them, and the entire picture becomes fuzzy at best, dangerous at worst.
During and after the COVID-19 pandemic, STI screening plummeted across almost every setting, especially in non-urgent care. A Lancet study found that clinic-based STI testing in urban populations dropped up to 40% between 2019 and 2023. In parallel, STI diagnoses appeared to fall. But positivity rates either remained stable or climbed, meaning fewer people were being tested, but a higher percentage were coming back positive when they did test.
That’s not a sign of improvement. It’s a flashing red warning that infections are being missed.
The Role of At-Home Tests, and Where They Fit In
At-home rapid tests have made testing more accessible for people who want privacy or don’t live near a clinic. They’re discreet, quick, and empowering. But they’re also limited. Some infections, like herpes and syphilis, aren’t easy to detect in the earliest stages using home kits. And false negatives are more likely if you don’t follow timing guidelines or use the right technique.
This is why we always recommend pairing home testing with accurate timing, and understanding when a negative result might mean “not yet” instead of “not infected.”
If you’ve recently had a risky exposure and need clarity, don’t wait for symptoms to appear. This FDA-cleared combo test kit checks for the most common STDs from the privacy of your home and helps bridge the gap between anxiety and action.
How PrEP and Prevention Programs Skew the Numbers
In a downtown San Francisco clinic, Dr. Lila Tran sees dozens of patients each week who are on PrEP, the daily HIV prevention medication. Most of them are diligent. They show up every three months for routine HIV and STI screening, and many have built a rhythm around testing. But Dr. Tran has noticed something strange: her clinic’s STI numbers look inflated compared to the city’s reported average.
“It’s not that our patients are getting infected more,” she explains. “It’s that we’re catching more because we’re actually testing.”
Here’s the catch: areas with robust PrEP programs and sexual health outreach will often report higher STI numbers, simply because they’re looking more carefully. Meanwhile, under-resourced areas, often rural, lower income, or serving marginalized groups, report fewer cases because fewer people are tested. This skews the national picture and can create a dangerous myth: that STIs are under control.
In reality, they may just be under the radar.
False Comfort in “Good Numbers”
Humans love clean data. We want to believe that fewer numbers mean fewer problems. But in STI surveillance, clean numbers often come from dirty data. Missing diagnoses, delayed testing, inaccessible clinics, all of these create the illusion that we’re doing better than we are.
Tyrell, 31, works in public health data analysis. He knows how numbers get interpreted, especially by people without context. When his city showed a drop in gonorrhea cases last year, news outlets called it a “public health win.” But Tyrell knew better. The drop correlated almost exactly with a staffing shortage that forced three testing centers to cut hours by 60%.
“We weren’t diagnosing fewer cases,” he says. “We were missing them.”
This is why it’s essential to read between the headlines. A decline in reported infections can be real, but it’s not automatically good news. We have to ask: are fewer people getting sick, or are fewer people getting checked?

People are also reading: Still Have Symptoms? You Might Be on the Wrong STD Antibiotic
Global Patterns vs Local Truths
On a global scale, STI trends look chaotic. The World Health Organization recently flagged a major rise in syphilis worldwide, particularly among women and babies. Meanwhile, countries like Canada and Australia have reported spikes in gonorrhea and syphilis over the past three years. And in the U.S., the CDC’s own data shows overall STI levels remain significantly higher than pre-2014 levels, even with the recent drop in reported cases.
So while headlines might say “STIs Are Dropping,” context matters. In some cities, yes. In some communities, no. And in some populations, like queer men and transgender people, STI rates are not just steady, they're climbing, especially for syphilis and HIV.
Public health is never one-size-fits-all. And when testing becomes less common in certain groups, those groups vanish from the data, creating false narratives that can be deeply harmful.
Table: Reasons STI Cases May Seem Lower (But Aren’t)
| Factor | Effect on Reported Rates | True Risk Level |
|---|---|---|
| Fewer people getting tested | Fewer cases detected and reported | Unchanged or higher |
| Testing limited to symptomatic people only | Artificial drop in “total” cases | Underestimates silent spread |
| Clinic closures or reduced hours | Data gaps and delays | Missed diagnoses |
| PrEP users tested regularly | Higher case count in those groups | Actual risk may be managed |
| People testing too early after exposure | False negatives not counted in totals | Infections still present |
Figure 3. Reported STI declines often mask testing gaps, access issues, or diagnostic timing problems that leave true infection rates underestimated.
Order Now $149.00 $392.00 Check Your STD Status in Minutes
Test at Home with Remedium
8-in-1 STD Test Kit
For Men & Women
Results in Minutes
No Lab Needed
Private & Discreet
For all 8 tests
How to Protect Yourself When the Numbers Don’t Help
If all of this leaves you feeling confused or skeptical, you’re not alone. Data can guide, but it can also mislead if interpreted in isolation. The best protection isn’t to trust the trendlines, but to trust your own timeline. Know when you were exposed. Know when to test. Know when to retest if needed.
Don’t wait for your local clinic to tell you what’s going around. If you’ve had unprotected sex, a new partner, or even a gut feeling that something’s off, get tested. Not because a chart says you should, but because your health deserves clarity.
And if you don’t have easy access to a clinic or just want privacy, STD Rapid Test Kits offers discreet at-home tests for common infections. Because the real numbers that matter aren’t on spreadsheets, they’re in your body.
FAQs
1. Wait, are STI rates actually going down, or not?
Good question. The short answer? Kind of. Reported cases have dropped in some places, but that’s often because fewer people are getting tested, not because fewer people are getting infected. It’s like checking your bank account less and assuming your balance is fine. Testing = visibility. Less testing = blurry picture.
2. If I tested negative, could I still have something?
Yep, especially if you tested too soon after exposure. That window period is sneaky. For something like chlamydia, you might need 7–14 days before a test can even pick it up. For herpes or syphilis, the wait is even longer. It’s like trying to detect smoke before the fire starts, timing matters.
3. Why are so many people skipping STI testing lately?
A mix of burnout, cost, clinic closures, and good old-fashioned denial. COVID-era disruptions made regular sexual health checks less routine, and a lot of people just never went back. Plus, if you feel fine, it’s easy to assume you’re in the clear. But STIs love to be quiet, and spread anyway.
4. Do at-home STI tests work?
They do, especially when used at the right time. At-home kits like ours are designed for privacy, speed, and convenience. But they’re not magic wands. If you test too early or don’t follow the instructions closely, you might get a false negative. Think of them as a powerful first step, not a final word if something feels off.
5. What if I only hook up with “clean” partners?
Let’s talk about that word, “clean.” It sounds judgmental and, honestly, outdated. A lot of people with STIs don't know they have them. Your partner might be telling the truth and not look sick. Testing is not about labels or assumptions; it's about respect and safety.
6. How frequently should I undergo testing?
If you’re sexually active, especially with new or multiple partners, once a year is a good baseline. Every three to six months if you’re on PrEP, have casual partners, or are part of a higher-risk community. More often if anything weird shows up or your partner gets diagnosed. Think of it like dental cleanings, but for your sex life.
7. Do false negatives really happen that often?
More than you’d think. Especially when people test too early after exposure. It’s not the test’s fault, it’s just that your body hasn’t produced enough of a signal yet. We’ve seen people test negative for gonorrhea on day five, then positive by day ten. When in doubt? Retest, don’t guess.
8. Is it true that STIs are worse in certain communities?
Certain communities do bear a greater burden, but not as a result of their actions. It has to do with structural inequality, bias, and access. For instance, testing, treatment, and follow-up care are frequently more difficult for Black and Latino populations. That is a matter of public health, not morality. Equity is important.
9. Why do STI rates look higher in cities than rural areas?
Because cities usually have more testing programs. More clinics = more diagnoses. In rural areas, it’s often the opposite: few places to get tested, so fewer cases reported. That doesn’t mean fewer infections, it just means fewer receipts.
10. Should I wait for symptoms before getting tested?
Nope. That’s like waiting for a flat tire to drive off the rim. Many STIs, especially chlamydia, HPV, and herpes, can hang out silently for weeks, months, or longer. By the time you feel something, complications may already be brewing. Prevention beats panic every time.
You Deserve Answers, Not Assumptions
It’s easy to cling to hopeful headlines, who wouldn’t want to believe STI rates are dropping? But the truth is more complicated. Behind every “decline” might be a missed test, a closed clinic, a person who skipped screening because they felt fine. Lower numbers don’t always mean less risk. They sometimes just mean less data.
So if your last test was a while ago, or if you’re sitting with that “what if?” after a recent encounter, don’t wait for the news to tell you it’s time. This at-home combo test kit can check for the most common STDs with privacy, speed, and clarity.
How We Sourced This Article: We combined current guidance from leading medical organizations with peer-reviewed research and lived-experience reporting to make this guide practical, compassionate, and accurate.
Sources
2. Nuffield Trust: Effectiveness of Sexual Health Services
3. WHO: Global STI Surveillance Update 2024
4. Global Reporting for STIs 2025 — WHO
5. Estimated Effect of Reduced Asymptomatic Testing on Missed Chlamydia Diagnoses
6. Updates on STE Testing, Treatment, and Prevention — IAS–USA
7. Study: Increased STI Diagnoses Due to More Testing — EACS 2025
About the Author
Dr. F. David, MD is a board-certified infectious disease specialist focused on STI prevention, diagnosis, and treatment. He blends clinical precision with a no-nonsense, sex-positive approach and is committed to expanding access for readers in both urban and off-grid settings.
Reviewed by: Shannon Velez, RN, MPH | Last medically reviewed: December 2025
This article should not be used as a substitute for medical advice; it is meant to be informative.





